Clinical Trial Update: Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ziprasidone augmentation of SSRI therapy in adults with major depressive disorder who did not adequately respond to SSRIs; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Geodon (Ziprasidone)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2014-07-03